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Summary 
Coliphage ;L employs systems of transcription termi- 
nation and antitermination to regulate gene expres- 
sion. Early gene expression is regulated by the 
phage-encoded N protein working with a series of 
Escherichia coil proteins, Nus, at RNA sites, NUT, to 
modify RNA polymerase to a termination-resistant 
form. Expression of ;L late genes is regulated by the 
phage-encoded Q antitermination protein. Q, which 
appears to use only one host factor, acts at a DNA 
site, qut, to modify RNA polymerase to a termination- 
resistant form. This review focuses on recent studies 
which show that: (i) N can mediate antitermination in 
vitro, independent of Nus proteins. (ii) Early genes in 
another lambdoid phage HK022 are also regulated by 
antitermination, where only an RNA signal appears 
necessary and sufficient to create a termination- 
resistant RNA polymerase. (iii) A part of the qut signal 
appears to be read from the non-template DNA strand. 
(iv) A host-encoded inhibitor of N antitermination 
appears to act through the NUT site as well as with 
the a subunit of RNA polymerase, and is antagonized 
by NusB protein. 
Introduction 
The strategy of controlling gene expression by modulating 
transcription termination was discovered in coliphage ;~ 
(Roberts, 1969). Roberts proposed that the N gene pro- 
duct of ;~, which was known to be required for the synthesis 
of nearly all ;~ transcripts, acts to permit transcripts initiat- 
ing at the early ;~ promoters to override Rho-dependent 
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termination signals. This proposal was based on his stu- 
dies identifying Rho-dependent termination signals in ;L 
as well as on a wealth of well-characterized mutants and 
variants of ;L. Following this seminal proposal, in vivo and 
in vitro studies contributed to a more sophisticated under- 
standing of N-mediated transcription antitermination. More- 
over, additional regulatory systems based on transcription 
termination were identified in X (Roberts, 1992), and related 
phages (Franklin, 1985) as well as in bacteria (Landick and 
Turnbough, 1992) and eukaryotes (Spencer and Grou- 
dine, 1990; Jones and Peterlin, 1994). A second class of 
transcription terminators, Rho- or factor-independent, has 
also been identified (Yager and Hippel, 1987). N-modified 
transcription also overrides this type of terminator (Gottes- 
man et al., 1980; DeVito and Das, 1994). 
Studies on the ;L transcription-antitermination systems 
continue to serve as primary sources for new insights 
into the process of transcription elongation, in eukaryotes 
as well as prokaryotes (Das, 1993; Greenblatt et aL, 1993). 
Therefore, this review will focus on termination and anti- 
termination regulatory systems in the lambdoid phages. 
Over the last few years there have been a number of excel- 
lent reviews on the topic of transcription antitermination, 
focusing on the well-characterized N and Q systems of X 
(reviews are listed before each section in the Prologue). 
We refer the reader to those reviews for detailed discus- 
sions of N and Q as well as references to the older 
literature. We will limit our discussion to an abbreviated 
summary of the material that has been previously reviewed 
and focus on the more recent findings hoping to update 
the readers on material with which they may not be 
familiar. 
PROLOGUE 
The N system 
(Reviewed in: Das, 1992; Das, 1993; Roberts, 1993; Green- 
blatt et al., 1993; Greenblatt, 1992; Friedman, 1988; Fried- 
man and Gottesman, 1983.) 
Early-gene transcription of the ;L genome originates at two 
promoters, pL (leftward) and pR (rightward), proceeding 
in opposite directions (Fig. 1). Transcription on the left 
passes through the N gene and, on the right the cro 
gene, before encountering Rho-dependent terminators 
tL1 and tR1 respectively. Approximately 50% of the tran- 
scripts initiating at pR terminate at tR1, with the remainder 
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Fig. 1. Map of the regulatory region of X detailing transcription 
patterns. To orient the reader, a representative collection of genes 
are shown at the top of the figure. The N and Q genes are 
discussed in the text. The nin region (Court and Sato, 1969) is 
defined by a 2.8 kb deletion (Fiandt et al., 1971) that removes three 
regions of transcription termination (Cheng et aL, 1995). The 
following lists the activities of the products of genes not discussed 
in detail in the text: repressors, cl and cro; transcription activator, 
cll; replication, O and P. The position of regulatory signals are 
shown below the listing of genes: small open boxes, terminators; 
large filled boxes, nut sites; open circles, promoters. Transcription 
patterns in the presence and absence of the N and Q 
antitermination proteins as well as associated Nus factors are 
shown beneath the map of the regulatory region. 
continuing through O and P and terminating in the collec- 
tion of Rho-dependent and factor-independent terminators 
in the nin region. In the presence of N, transcription trans- 
cends these termination barriers and, consequently, more 
distal genes are expressed. In fact, if X is integrated into the 
bacterial chromosome, modified transcription can extend 
for over tens of kilobases into the bacterial chromosome, 
overriding a wide range of both Rho-dependent and Rho- 
independent terminators. 
In addition to N, a number of host proteins, Nus, are 
required for N-mediated antitermination. A role for these 
proteins was, in most cases, first deduced from genetic 
experiments with mutants that were unable to support N 
action. Identification of the affected genes and demonstra- 
tion that they were recessive showed that the mutations 
affect a required activity and lead to the identification of 
the products. In vitro studies confirmed that these products 
were required for N action. Some of the Nus factors had 
previously been unidentified while others are proteins of 
known function. NusA, a 56kDa essential protein, was 
subsequently shown to affect transcriptional pausing, ter- 
mination, and antitermination. NusB, a 14 kDa protein essen- 
tial for cell growth only at low temperatures, may be involved 
in translation as well as transcription. The nusE71 mutation, 
which defined the NusE product, is an allele of rpsJ, encoding 
ribosomal protein $10. NusD was identified as the termi- 
nation factor Rho. NusG, first identified through a nusG 
mutation that suppressed the effects of the nusA1 and 
nusE71 mutations, is a required factor for the N antitermi- 
nation in vitro as well as an enhancer of termination factor 
Rho. The N and Nus proteins function as a complex modi- 
fying RNA polymerase to a termination-resistant form. 
The N-Nus complex is assembled at sites, NUT, 
located downstream of the pL and pR promoters (see 
Figs 1 and 2). Transcription initiates at pR and traverses 
the cro gene before reaching the nut sequence. The 
NUT signals, read from the RNA, have been divided into 
two components, BOXes A and B, with an intervening 
spacer region (Fig. 2). The boxA sequence is conserved 
not only amongst lambdoid phages but also within the anti- 
terminator elements of the rm operons. The BOX-B 
sequence forms a stem-loop structure in the RNA. In 
vitro studies suggest that as soon as NUT RNA is synthe- 
sized, N and Nus factors assemble into a complex and 
associate with RNA polymerase (Fig. 2). These studies 
also suggest that the assembled complex remains associ- 
ated with the RNA polymerase as it continues transcrip- 
tion. The NUT RNA may be part of the complex. In this 
way, the polymerase is modified and retains antitermina- 
tion activity as it transcribes kilobases of DNA. Both in 
vivo and in vitro evidence indicate that host factor NusB, 
in complex with NusE, binds to BOX-A, and N protein 
binds to the loop of BOX-B. 
All lambdoid phages have mechanisms for converting 
transcription complexes initiating at early promoters to 
termination-resistant forms. With one exception (to be dis- 
cussed below), those studied have systems analogous to 
the N system of X. The two other characterized N systems 
are those of phages 21 and P22. In those cases, N genes 
and nutsites are located at positions on these phage gen- 
omes that are analogous to the positions of their ,L homo- 
Iogues. Despite these similarities, products of the N 
genes of different lambdoid phages are specific for their 
cognate NUT sites under physiological conditions. The 
arginine-rich amino terminus of N recognizes the BOX-B 
region of NUT. A consensus boxA sequence was deduced 
from a comparison of boxA sequences and shown to be 
more effective than that found in the X nut region. Both in 
vivo and in vitro studies suggest that NusB and possibly 
$10 (NusE) interact with BOX-A, with the consensus 
BOX-A being the most effective binder. 
The Q sys tem 
(Reviewed in: Roberts, 1992.) 
N-modified transcription from pR passes through tR1 and 
the Rho-independent (tR2) and Rho-dependent (tR3 and 
tR4) barriers in the nin region before extending into the 
Q gene (Fig. 1). The Q gene product is the primary factor 
in a second X antitermination system allowing transcription 
initiating at the pR' promoter, immediately beyond Q, to 
extend downstream to include the lytic genes. Q-mediated 
antitermination, like that of N, requires a specific recog- 
nition signal, termed qu t .  However, Q, unlike N, does 
not bind to the RNA but binds to DNA in the region between 
the - 1 0  and - 35 promoter elements and interacts with 
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Fig. 2. Hypothetical representation of possible 
interactions in the formation of the N-mediated 
antitermination complex under conditions 
where NusB either succeeds or fails to block 
action of the putative inhibitor. In each panel, 
RNA polymerase is shown associated with 
Nus factors at the NUT-L site. The carboxy 
terminus (CT) of the ~ subunit of RNA 
polymerese is indicated. The positions of 
boxes A and B as well as the intervening 
spacer are also indicated. The boxA5 
mutation (shown in bold) is thought to 
enhance inhibitor binding. 
A. The active complex may form when NusB 
binds to 8OX-A and effectively blocks action 
of the inhibitor. 
B. How the inhibitor may be positioned to 
effectively block productive complex formation 
by binding to BOX-A and the carboxy 
terminus of ~, 
C. How absence of the carboxy terminus (CT) 
of ¢ might reduce inhibitor binding to the 
complex. 
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RNA polymerase paused just downstream at +16 relative 
to the start of transcription. Also, unlike the N system, 
only one host factor, NusA, has been implicated in Q 
action. 
Studies with Q, as well as N, suggest that antiterminator 
activity reduces pausing by RNA polymerase and thus 
conceivably propels polymerase through termination 
sites. Reduction in pausing could be the most obvious 
manifestation of the ability of antiterminators to increase 
the kinetics of utilization of ribonucleotide substrates. 
The Nun termination protein 
(Reviewed in: Friedman, 1988; Das, 1993; Gottesman and 
Weisberg, 1995.) 
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Perhaps the most striking finding since the characteriza- 
tion of N antitermination is the elucidation of the action of 
the Nun protein encoded by lambdoid phage HK022. 
Located at the analogous position on the HK022 genome 
as the N genes of other lambdoid phages, the nun gene 
encodes a protein, Nun, that resembles the N family of 
proteins. However, Nun is dispensable for HK022 growth 
and there is no evidence that it plays any role in HK022 
development, either lytic or lysogenic. Surprisingly, Nun 
protein acts at the NUT sites of X, but unlike N causes tran- 
scription termination not antitermination. Therefore, an 
HK022 lysogen excludes growth of an infecting X by caus- 
ing premature termination of X transcripts. Like N, action of 
Nun requires the host Nus proteins. What is particularly 
striking is the specificity of the exclusion; of the lambdoid 
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phages tested, only those with the nut region of ;~. are 
excluded. 
NEW INFORMATION 
Minimal requirements for N-mediated antitermination 
Earlier studies using in vitro systems defined the several 
components of N-mediated antitermination (reviewed in: 
Das, 1992; 1993; Greenblatt, 1992; Greenblatt et al., 
1993). Studies characterizing antitermination through 
one terminator revealed a requirement for only N and 
NusA (Whalen et aL, 1988). These authors suggest that 
the added factors provide processivity and stability to the 
antiterminating transcription complex. Consistent with 
this argument, persistent antitermination through multiple 
terminators required, in addition, NusB, $10 (NusE), and 
NusG (Mason et aL, 1992a). More recently, De Vito and 
Das (1994) demonstrated efficient antitermination over 
short distances with N alone, but only if N was supplied 
at high concentrations. They also showed that persistent 
antitermination through a number of terminators over 
longer distances required, in addition to N, NusA, $10 
(NusE), and NusG. Strikingly, NusB was not required for 
reasonable levels of persistent antitermination, although 
it was required for maximally effective levels. These results 
suggest that the essential component directing antitermi- 
nation is N and that NusB is the most dispensable for per- 
sistent antitermination in vitro. 
Studies by Chattopadhyay et aL (1995) employing 
mobility-shift- and RNase-protection experiments provided 
evidence that N binds to the 5' leading side of the stem and 
loop portion of BOX-B. In addition, these studies demon- 
strated that some changes in the sequence of the BOX-B 
loop interfere with N binding and antitermination, while 
other changes do not affect N binding but do interfere 
with the minimal N-NusA antitermination reaction. These 
observations led Chattopadhyay et aL (1995) to propose 
that through an association of both N and NusA with 
BOX-B, NusA helps to bring N in contact with RNA poly- 
merase to create the antitermination complex. At higher 
N concentrations, the requirement for NusA is eliminated 
(DeVito and Das, 1994). 
We emphasize that although the N system in vivo 
requires a number of proteins in addition to N, N in conjunc- 
tion with a BOX-B stem and loop structure is sufficient to con- 
vert RNA polymerase to a termination-resistant form. If 
antitermination can be made so simple, obvious questions 
raised by this work are why in vivo is the N system compli- 
cated by so many factors, and is a complicated system 
necessary? We will argue that the added factors permit 
multiple levels of regulation through N-mediated antitermi- 
nation and review newly identified components of the N-  
Nus system that offer the possibilities of additional levels 
of regulation. We will also review studies characterizing 
other antitermination systems of lambdoid phages that 
suggest that simpler systems also exist. 
Regulation of ;L N gene expression 
The focus of studies on N has primarily been directed 
toward understanding its role as an antitermination protein 
with little effort directed toward understanding the regula- 
tion of N expression. Classically, it had been shown that 
N, the first gene transcribed from pL, is controlled by 
repressor and Cro proteins, both of which bind to operator 
sites, and respectively shut off or turn down transcription 
from pR and pL (Ptashne, 1992). N levels are also con- 
trolled post-translationally by the Lon protease, which 
rapidly degrades the N protein (Gottesman et aL, 1981). 
Recent studies have shown that N can be further con- 
trolled at the level of translation by the RNA endonuclease 
RNase III (Kameyama etal., 1991). The AUG start of N is 
located 223 nucleotides (nt) from the start of transcription. 
This long RNA leader contains the NUT-L site, encom- 
passing nt 34-64. Between NUT-L and the AUG start is a 
large base-paired stem-loop structure that abuts the N 
ribosome-binding site and inhibits initiation of translation. 
RNase Ill cleaves the structure, opening the ribosome- 
binding site to allow more efficient translation of N. Since 
RNaselll has a regulatory role in E. coil (Court, 1993), it 
seems likely that ~, through N expression, has added 
this regulatory scheme to the already large panoply of reg- 
ulatory mechanisms operating on transcription from its 
early promoters. 
HK022 Nun protein 
Building on the earlier observations that HK022 Nun pro- 
tein acted at ~ NUT sites to terminate transcription from 
early X promoters, Baron and Weisberg (1992) showed 
that both the boxA and boxB components of the ).~ nut 
sequences are required for maximal Nun-mediated tran- 
scription termination. However, results of this mutational 
analysis also suggested that although there is significant 
overlap in the recognition of N and Nun, the recognition 
sequences in nut are not identical. Using a suppressor 
tRNA located immediately downstream from the ;,~ nutL 
sequence as the reporter, Sloan and Weisberg (1993) 
showed that, in vivo, Nun reduced the level of biologically 
active suppressor tRNA and that most of the RNA termi- 
nated in a region about 100 nt downstream of nutL. 
Also, similar to N, Nun action requires host Nus proteins. 
Mutations in Escherichia coil nus genes that cause a failure 
in N-mediated antitermination also affect Nun-mediated ter- 
mination (Robert et aL, 1987; Robledo et aL, 1990). More- 
over, other mutations in these nus genes have been 
isolated that reduce Nun action but not N action (Robledo 
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et aL, 1991). Selected as inhibitors of Nun termination at 
NUT-R, surprisingly, the latter mutations have no effect 
on Nun termination at NUT-L. Identification of a host 
mutation, rpoClO0, that interferes with Nun-directed termi- 
nation suggests a role for the I~' subunit of RNA polymer- 
ase in transcription termination (Robledo et aL, 1991). 
In vitro experiments show that, as does N, Nun functions 
efficiently in the presence of all of the purified Nus factors, 
but in this case transcription arrest is the end result (Hung 
and Gottesman, 1995). Moreover, Nun also functions in a 
minimal system with BOX-B, independently of Nus factors. 
Chimeric proteins expressed from hybrid genes created 
by in vitro splicing of N and nun genes have been used to 
relate function and structure of Nun (K. Henthorn and D. 
Friedman, in preparation). The proteins expressed from 
these genes were tested for termination and/or antitermi- 
nation activity. These experiments, that show that the 
RNA-binding domains of N and Nun are exchangeable, 
are consistent with the RNA-recognition element being 
located in the amino-terminal portion and a transcription- 
regulating element being located in the carboxy portion 
of Nun. This assignment is consistent with previous studies 
showing that the RNA-binding domain of N is in the amino- 
terminal region of that protein (Lazinski et aL, 1989; Frank- 
lin, 1993). One chimera, having the amino 3/4 N protein 
and the carboxy 1/4 Nun protein, exhibits the unusual 
property of blocking antitermination when rpoC is wild 
type, and promoting antitermination with the rpoClO0 
mutant allele that normally interferes with Nun termination. 
This observation strengthens the argument that interac- 
tions with the 9' subunit may play an important role in 
determining the elongation mode of RNA polymerase. 
Antitermination in HK022 
HK022 early-gene organization is similar to that of X, and 
also like X, HK022 requires transcription antitermination 
for expression of its Q gene. However, we remind the 
reader that the nun gene, while occupying a position on 
the HK022 genome analogous to the position of N on the 
X genome, does not appear to function as an antiter- 
mination protein (Robert et aL, 1987). Although there is 
no evidence that HK022 has an antitermination function 
analogous to X N, there are sites downstream of the 
early promoters that have similar sequences and are 
required for transcription antitermination. These common 
sites, composed of two sequences called box1 and box2, 
have dyad symmetry and the potential to form a stem 
and loop structure in the RNA (Oberto et aL, 1993). 
These sequences, however, appear otherwise unrelated 
to the boxA and boxB sequences of the nut regions of X 
and other lambdoid phages. More surprisingly, an 
HK022-encoded protein does not appear to be necessary 
when a termination-resistant transcription complex is 
© 1995 Blackwell Science Ltd, Molecular Microbiology, 18, 191-200 
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formed by RNA polymerase transcribing the box1 and 
box2 region of HK022. 
If the only contribution of HK022 to this transcription 
antitermination reaction is the RNA sequence, is there 
then an N-like factor expressed by the host that acts at 
or near BOX 1 and BOX 2? Weisberg and co-workers 
(Clerget et aL, 1995) addressed this question by looking 
for E. coil mutants that fail to support this antitermination. 
The only mutations identified were in rpoC. No evidence 
for Nus-like or N-like factors was uncovered. One explana- 
tion for these results is that a protein is not required for anti- 
termination from the early promoters of HK022, but rather 
it is the interaction of RNA sequences with RNA polymer- 
ase that produces the termination-resistant complex. If 
the RNA always assumes the same structure after tran- 
scription, then it is possible that transcription from the 
HK022 early promoters always antiterminates, without 
the delay required for N systems. This raises an interesting 
question related to N-mediated antitermination. Is the NUT 
RNA the ultimate determinant for antitermination, with the 
various proteins, including N, only playing supporting reg- 
ulatory roles? 
Q function 
Most of our knowledge of Q action derives from in vitro 
studies from the Roberts laboratory. They have focused 
their efforts on the Q genes of X and its relative, phage 
82. Their studies indicate that RNA polymerase binds at 
pR' and proceeds to pause sites located, relative to the 
transcription start, at +16 or 17 in X (Grayhack et aL, 
1985) and + 25 in 82 (Goliger and Roberts, 1989). Poly- 
merases, paused at these sites, are the substrate for Q. 
Mutational analysis and DNA footprinting studies indicate 
that the X Q recognition site, qut, may span a segment 
from within the pR' promoter to + 9 relative to the transcrip- 
tion start (Yarnell and Roberts, 1992). For this reason qut 
and Q action cannot be separated from the pR' promoter. 
This is unlike N, where unrelated promoters function effec- 
tively in N-mediated antitermination providing that the nut 
site is promoter distal and placed upstream of any termina- 
tors (De Crombrugghe et aL, 1979). 
;~ pR' DNA templates, mutant at positions + 2 and + 6, 
reduce RNA polymerase pausing and prevent Q binding 
to the antitermination complex. Heteroduplex DNA con- 
taining these same changes but only in the non-template 
(non-transcribed) strand exert the same effect, whereas 
heteroduplexes with these changes only in the template 
(transcribed) strand have little, if any, effect on pausing 
or Q function (Ring and Roberts, 1994). We emphasize 
the point that this signal is recognized in the non- 
transcribed DNA strand and not the RNA or the tran- 
scribed DNA strand. Since RNA polymerase incorporating 
the 16th nt would cause the DNA region including + 2 and 
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+ 6 to be melted and thus become part of the transcription 
bubble, the non-transcribed strand could be free to interact 
with RNA polymerase to cause pausing, a mechanism 
which is suggested by heteroduplex analysis as well as 
in vivo- and in vitro -footprint studies. Pausing of polymer- 
ase at +16 is not sufficient to foster Q interaction, since a 
polymerase can be paused artificially at +16 on DNA 
templates, mutant at + 2 or + 6, and there is no Q binding 
(Yarnell and Roberts, 1992). Thus, either Q itself recog- 
nizes these positions in the non-transcribed strand or Q 
recognizes a form of RNA polymerase that is altered by 
an interaction with nucleotides in the nontranscribed 
strand at these positions to facilitate pausing and inter- 
action with Q. 
Q is distinquishable from N in another important way; it 
is an example of an antitermination protein that acts with- 
out an array of other proteins (Barik and Das, 1990), requir- 
ing only one additional protein, NusA (Grayhack et aL, 
1985). Moreover, that requirement does not appear to be 
absolute (Goliger and Roberts, 1989). Thus, Q protein, 
with a qut site, is sufficient to cause antitermination, and 
NusA only stimulates the effect. Studies with an E. coil 
carrying a nusA gene inactivated by a deletion-insertion, 
discussed in detail below, confirms that Q-mediated anti- 
termination is effective without NusA (C. Zheng, D. L. 
Court, and D. I. Friedman, unpublished). Importantly, ;,~ 
grows in this host, while a ~ Q derivative fails to grow, 
indicating a requirement for Q action even in the absence 
of any NusA. In some ways, the Q system resembles the 
minimal N system, where high concentrations of N are suf- 
ficient for antitermination in the absence of Nus factors. 
The difference, however, is that the Q system is more pro- 
cessive than the minimal N system. Perhaps the basis for 
this difference resides in two elements that may be specific 
for Q, the paused RNA potymerase intermediate at the qut 
site, and the involvement of the nontemplate DNA strand. 
The inhibitor 
One focus of this review has been the complexity of the N 
antitermination system which is influenced by a large num- 
ber of host proteins. This stands in distinct contrast to the 
simpler Q system that is modulated by, perhaps, one addi- 
tional protein, and the even simpler early antitermination 
system of HK022 that apparently requires only an RNA 
sequence. This complexity takes an added turn when we 
now examine the possibility of an additional factor that inhi- 
bits N action. The hypothesis that a factor exists that acts at 
BOX-A to inhibit N-mediated antitermination (Patterson et 
aL, 1994) emerged from two lines of apparently contradic- 
tory evidence. First, it was found that point mutations in 
boxA (boxA5 or boxA 16) inactivate the nut site (Olson et 
aL, 1984; Robledo et aL, 1990). Second, it was found 
that deletions that included boxA appear to have little 
effect on antitermination through Rho-dependent and 
Rho-independent termination signals (Patterson et aL, 
1994; Peltz et aL, 1985; Zuber et aL, 1987). Moreover, 
nut sites with those deletions direct antitermination inde- 
pendently of NusB, while still requiring N and the other 
Nus factors. These paradoxical observations can be 
explained by postulating that an inhibitory molecule recog- 
nizes BOX-A and that NusB competitively blocks the action 
of the inhibitor in wild-type situations (Fig. 2). Moreover, as 
a corollary, it was postulated that a nut region with the 
BOXA-5 mutation is a preferred target for the inhibitor, 
explaining why a deletion of boxA is less detrimental to 
N-mediated antitermination than is the boxA5 mutation. 
Although this proposed role for NusB action was based 
more on deduction than direct evidence, subsequent 
studies have lent significant credence to the model. 
We discuss four results supporting the model and its cor- 
ollary. First, high level expression of transcripts from a 
plasmid containing a nut region with the boxA5 mutation 
suppressed the nusB5 mutation for growth of ;'~ (Patterson 
et aL, 1994). It was argued that excess boxA5 transcripts 
selectively titrate a diffusible inhibitor, lowering its func- 
tional levels, and thereby freeing other NUT sites on ;~ tran- 
scripts from inhibitor and reducing the requirement for 
NusB. Second, the nusBl01 mutation suppresses the N 
antitermination defects of mutations in the nus A and E 
genes in a boxA-dependent manner (Court et al., 1995). 
As described above, in anus  + host, the boxA region of 
nutR can be deleted without preventing antitermination, 
but the suppressor activity of nusBl01 is not observed 
if the boxA sequence is deleted. Third, NusB and $10 
are required for the in vitro-antitermination reaction con- 
trolled by the BOX-A sequence of the leader region of 
the rrn operons of E. coli (Squires et aL, 1993) and bind 
specifically to the consensus BOX-A RNA sequence from 
an rrn leader region (Nodwell and Greenbtatt, 1993). Fourth, 
DeVito and Das (1994) argue that the dispensability of 
NusB for persistent in vitro antitermination in a purified 
system is consistent with its role as an antagonist of an 
inhibitory function; in the in vitro reaction where there 
appears to be no inhibitor, NusB is not needed for effective 
antitermination. 
Role of the e subunit  of RNA polymerase 
Several transcription factors in E. coil (e.g., Crp, Fnr, IHF, 
and OmpR-EnvZ, as well as the phage P20gr  protein) 
exert their action through contact with the ~ subunit of 
RNA polymerase (reviewed in: Ishihama, 1992; Russo 
and Silhavy, 1992; Busby and Ebright, 1994). These inter- 
actions have been identified by mutations in rpoA, the 
gene encoding the :z subunit. Different point mutations 
located in different positions of the carboxy-terminal 
domain (CTD) of rpoA show specificity by blocking the 
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action of specific transcription factors. This suggests that 
different activators contact different amino acid patches 
of the carboxy domain of ~. A variant = deleted for the 
entire carboxy terminus has a general defect for all of the 
transcription factors tested. 
A newly identified rpoA mutation, D305E, suppresses 
the effects of nus mutations (nusA 1, nusB5, and nusE71) 
on N action (A. Schauer, S.-W. Cheng, L. St. Pierre, 
D. Alessi, D. Hidayetoglu, D. Court, and D. I. Friedman, 
submitted). The rpoAD305E mutation also changes an 
amino acid in the carboxy terminus of 0~. Initially, it was 
assumed that rpoAD305E might enhance an interaction 
of one of the components of the N-Nus complex with 
RNA polymerase, in this way compensating for an ineffec- 
tive interaction of the mutant Nus factors. Surprisingly, a 
truncated 0~, missing the CTD, exhibits suppression very 
similar to that by the D305Epoint mutation. If the mechan- 
ism of suppression by the point and deletion mutations are 
similar, then it is difficult to conceive how this would occur 
by an enhanced interaction favouring antitermination. 
Rather, under Nus- conditions, the carboxy terminus of 
appears inhibitory for N-mediated antitermination. 
How then do the rpoA mutations suppress the effect of 
nus mutations? Taking into consideration what we know 
about the ~ subunit and the N system, our attention is 
directed toward two types of sites on the ;L genome. The 
first are the early X promoters that are located upstream 
of the nut sites. An argument favouring these promoters 
as the responsible sites can be made on the basis of the 
in vivo studies showing that the wide array of contacts 
makes with proteins or DNA that play important roles in 
stimulating transcription, are at promoters. In fact, Giladi 
et aL (1992) have shown in vitro that = plays a regulatory 
role at the pL promoter. Perhaps an interaction at the 
early X promoters mediated through ~, altering RNA poly- 
merase per se or the rate of initiation, ultimately reduces 
the effectiveness of N-Nus complex formation at the nut 
site. Accordingly, the ~ mutations might interfere with the 
interaction at the promoter and thus facilitate complex- 
formation downstream at the nut site. This facilitated 
formation of N antitermination complexes would allow sup- 
pression of mutations that reduce N antitermination. 
The second are NUT RNAs, the sites of N-Nus-RNA 
polymerase complex assembly. In the previous section, 
we discussed a putative inhibitor of N-mediated antitermi- 
nation. Perhaps this inhibitor, positioned by BOX-A RNA, 
also interacts with rpoA (Fig. 2B). Deletion of the carboxy 
terminus of 0c or deletion of the boxA region prevent inter- 
action of the inhibitor with ~ (Fig 2C). This model provides 
a unifying explanation of how ~ and the inhibitor might be 
involved in N-mediated antitermination. An obvious candi- 
date for the inhibitor is the = CTD itself. This seems unlikely 
for two reasons. First, the fact that inhibitor activity can be 
titrated (Patterson et aL, 1994) means that the inhibitor 
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does not act as a component of RNA polymerase. Second, 
overproduction of ~ has little effect on X growth in vivo (L. 
St. Pierre, D. Court and D. Friedman, unpublished). 
Recent work suggests that the = subunit may also 
contact the nascent RNA strand through its carboxy termi- 
nus during elongation (Liu and Hanna, 1995). In vitro 
studies, in which a modified nucleotide capable of photo- 
crosslinking was placed at specific positions in the newly 
transcribed RNA, show that following photoactivation, resi- 
dues as far as 44 nt from the 3' end of the nascent RNA are 
crosslinked to the ~ subunit. Interestingly, when NusA is 
added to the transcription reaction, NusA becomes 
crossed-linked to RNA and the crosslinking of RNA to 
is not observed. 
Nus factors 
NusA 
A factor that plays a role in transcriptional pausing, termi- 
nation, and antitermination, NusA, is essential for E. coli, 
as shown by the identification of a number of conditional 
lethal mutations, including amber, ts, and cs (Craven and 
Friedman, 1991; Nakamura et aL, 1986; Nakamura and 
Uchida, 1983). However, E. coil can tolerate the absence 
of NusA providing it also has low Rho activity (Zheng and 
Friedman, 1994). This was shown by the construction of 
an E. coli with a 533 bp deletion of nusA substituted with 
a cat cassette (AnusA533) in a strain that also carries rho 
mutations that substantially reduce Rho termination activity. 
Results of a number of studies on Rho and NusA action 
provide an explanation for the viability of this double 
mutant . NusA protein reduces the elongation rate of 
RNA polymerase (Yager and Hippel, 1987), coupling tran- 
scription and translation (Landick and Turnbough, 1992; 
Das and Wolska, 1984; Kung et aL, 1975). Thus, trans- 
lation of genes with internal Rho-dependent terminators 
prevents premature transcription termination by Rho 
(Ruteshouser and Richardson, 1989). To terminate tran- 
scription, Rho must access, unencumbered, RNA some 
50-100 nt upstream of the site of termination and trans- 
locate to the paused polymerase. Bound ribosomes may 
either block the binding of Rho or its access to the down- 
stream paused polymerase. Nonsense mutations uncouple 
translation from transcription, allowing unimpeded access 
of Rho to the paused polymerase leading to transcription 
termination (Adhya et aL, 1976; Platt and Richardson, 
1992; Platt, 1994). It has been proposed (Zheng and Fried- 
man, 1994) that in the absence of NusA, as in the strain 
carrying AnusA533, RNA polymerase elongates more 
rapidly causing a general uncoupling of transcription and 
translation (Das and Wolska, 1984). This allows access 
by Rho to the paused polymerase, leading to premature 
transcription termination throughout the genome. This pre- 
mature termination is lethal to the cell. However, when Rho 
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activity is reduced by the compensating rho mutation, pre- 
mature termination is reduced and the cell can survive. 
NusB and NusE 
The functions NusB and $10 (NusE) appear to play roles in 
both transcription and translation. These two proteins inter- 
act with each other to form a complex (Mason et aL, 1992b) 
that binds to RNA containing the consensus BOX-A 
sequence (Nodwell and Greenblatt, 1993). Although such 
an interaction has not been demonstrated for the BOX-A 
sequence in the X nut region, biological studies indicate 
that NusB interacts with the X BOX-A sequence (Friedman 
et aL, 1990; Patterson et aL, 1994; Court et al., 1995). It 
has been proposed that the interaction of NusB with 
BOX-A can facilitate $10 interaction with RNA polymerase 
during N antitermination (Patterson et aL, 1994) (Fig. 2A). 
However, it is clear that both in vivo and in vitro $10 
remains essential for N-mediated antitermination reactions 
when boxA is deleted or NusB is not provided and thus can 
interact in the N-antitermination complex independently of 
NusB (Patterson et aL, 1994; DeVito and Das, 1994) 
(Fig. 2B). 
$10 is undoubtedly a translation factor because it is a 
protein component of the 30S ribosome subunit (Nomura 
and Morgan, 1977). Although NusB is not an integral ribo- 
somal protein, it does influence translation, as shown by 
the observation that nusB mutants have slowed translation 
rates relative to wild type (Taura et aL, 1992), and is asso- 
ciated with ribosomes following high-salt wash (Das and 
Wolska, 1984). NusB null mutants have the interesting 
property of being cold sensitive for growth (Taura et aL, 
1992; Georgopoulos et aL, 1980). At elevated tempera- 
tures, these nusB null mutants grow, but, as discussed 
above, exhibit reduced translation rates and a Nus- pheno- 
type (Taura et al., 1992). The nature of the cold-sensitivity 
defect is not yet understood (Court et aL, 1995). It is inter- 
esting to speculate that, as in the case of ;L in the absence 
of NusB, the proposed inhibitory function discussed in an 
earlier section, may prevent growth at low temperature; 
i.e. the inhibitor could cause the cold-sensitive phenotype. 
NusG and NusD (Rho) 
NusG is an essential function in E. coli (Sullivan and Got- 
tesman, 1992) and is a component of the transcription- 
elongation machinery (Li et aL, 1992). The gene was first 
identified by mutations that suppressed the N-antitermina- 
tion defect caused by the nusA1 mutation (Sullivan et aL, 
1992). In vivostudies showed that NusG is required for effi- 
cient Rho-mediated termination (Sullivan and Gottesman, 
1992). Experiments with simple transcription systems 
confirm the in vivo observations that Rho-mediated 
transcription termination is enhanced by NusG and also 
showed that there is a proximal shift toward the promoter 
in the position of Rho-terminated transcripts (Li et aL, 
1993; Nehrke et aL, 1993). 
During transcription elongation by RNA polymerase, the 
Rho hexamer binds to the free RNA, and NusG binds poly- 
merase. Although each individually binds weakly, together 
they stabilize one another (Li et aL, 1993) and thereby form 
a more stable and effective termination complex (Nehrke 
and Platt, 1994). In fact, some Rho-dependent termination 
sites are only active in vitro in the presence of Rho and 
NusG (Burns and Richardson, 1995). 
In vivo studies have not demonstrated a requirement 
for NusG in N-mediated antitermination (Sullivan and Got- 
tesman, 1992), although purified NusG was subsequently 
shown to enhance elongation in a pure N-dependent 
transcription-antitermination assay (Mason et aL, 1992a). 
NusG expressed from a multicopy plasmid can rescue 
the NusD026 (because of a rho mutation) defect on N- 
antitermination (Sullivan et al., 1992; Das et aL, 1983) sug- 
gesting that the NusD mutant lacks an efficient interaction 
with NusG in the N-antitermination complex. Indeed, an 
affinity-chromatography study showed that at higher tem- 
peratures where the wild type binds effectively, the 
Rho026 protein binds poorly to NusG (Li et aL, 1993). 
We suggest that Rho is an integral component of the anti- 
termination complex (Fig. 2) and that the Rho026 protein 
inhibits antitermination by compromising an important 
interaction of Rho and NusG within the complex. 
EPILOGUE 
Although the new information reviewed here has not 
revolutionized our thinking about N-mediated transcription 
antitermination, it has contributed to a more refined under- 
standing. It has focused attention on the ~' subunit of poly- 
merase as being a potentially major player in determining 
the fate of the transcription complex as well as the role an 
RNA site might play. Perhaps the most unexpected finding 
is the evidence suggesting a previously undescribed 
player, a diffusible inhibitor that antagonizes N-mediated 
antitermination. The inhibitor itself has not been identified, 
however, the circumstantial evidence from a number of 
experiments provides strong support for assuming its exis- 
tence. The anti-sigma factors (Duncan and Losick, 1993; 
Ohnishi et al., 1992) offer another example where an inhi- 
bitor is part of a regulatory scheme. Obviously, proof of this 
idea awaits the genetic and functional identification of the 
inhibitor. 
What role could such an inhibitory function play? Perhaps 
it serves with NusB as an important cellular component of 
the antitermination regulatory scheme, when conditions 
are either less favourable for the lytic pathway or more 
favourable for the lysogenic pathway. By interfering with 
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N-mediated antitermination, expression of genes encoding 
lytic functions located downstream of the transcription ter- 
minators would be decreased. 
The characterization of the antitermination mechanism 
in the early operons of HK022 adds a new twist to any con- 
sideration of the role of antitermination early in phage 
infection. If only the HK022 RNA site is required for anti- 
termination, then it is difficult to understand what advan- 
tage is offered to the rest of the lambdoid phages in 
having a special protein for antitermination. We emphasize 
our contention that the complex of proteins required for 
processive transcription antitermination by N plausibly 
accomodate multiple pathways for regulating ~, gene 
expression at an early step, immediately following the 
first initiation event. It follows from this argument that the 
antitermination system in the early operons of phage 
HK022 is more primitive than that of other lambdoid 
phages, at least if possible regulatory mechanisms are 
considered. 
We can offer several different, but not mutually exclu- 
sive, ways by which the addition of a protein component 
to an RNA signal for antitermination might provide further 
levels of regulation: (i) control of the efficiency of trans- 
lation of any of the antitermination proteins, (ii) control of 
the rate of the degradation of the protein(s), and (iii) the 
competition between a protein inhibitor and antitermination 
factors for an RNA site. All three of these possible modes 
of regulation, at least under some conditions, appear to be 
available to influence X N-mediated antitermination. 
The major question waiting to be answered is how the 
addition of N and Nus factors alters RNA polymerase so 
that it disregards both Rho-dependent and intrinsic termi- 
nation signals. 
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